Press Releases

COSTA MESA, Calif., Nov. 6, 2019 /PRNewswire/ -- The American Academy of Orthopaedic Surgeons (AAOS), the preeminent provider of education and practice management services for orthopaedic surgeons and allied health professionals has entered a new partnership with CareCredit, a leading health, wellness and personal care credit card business.

- New dynamic analyses of Phase 3 SIMPLIFY-1 transfusion data demonstrate that momelotinib patients are nearly 10-times more likely to remain transfusion free compared to ruxolitinib treated patients - VANCOUVER, Nov. 6, 2019 /PRNewswire/ - Sierra Oncology, Inc. (Nasdaq: SRRA), a late-stage drug development company focused on the development and co

Ms. Donna Parr and Dr. Niclas Stiernholm recruited to broaden public/private equity expertise TORONTO, Nov. 6, 2019 /PRNewswire/ - FACIT, a commercialization venture firm, reported on the expansion of its Executive-in-Residence program and new strategic initiatives. 

TARRYTOWN, N.Y., Nov. 6, 2019 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that it will share new and updated data for two investig

NEW YORK, Nov. 6, 2019 /PRNewswire/ -- Actinium Pharmaceuticals, Inc.  (NYSE AMERICAN: ATNM) ("Actinium") today announced that new findings from its pivotal Phase 3 SIERRA trial for Iomab-B (Iodine-131 apamistamab) that support its Iomab-ACT program for lymphodepletion for CAR-T and adoptive cell therapies has been accepted for presentation at the 2019 Americ

PHILADELPHIA, Nov. 6, 2019 /PRNewswire/ -- EIR Healthcare, the award-winning modular innovation firm bringing efficient industrial practices to healthcare, real estate and hospitality, annou

WALNUT CREEK, Calif., Nov. 6, 2019 /PRNewswire/ -- Paradigm, the industry leader in solving catastrophic and complex health care challenges and improving lives, today unveiled its newly enhanced Expert-Driven, Data-Guided (EDDG) platform. The EDDG platform uses proprietary case management data from Paradigm's nearly 30 years of experience serving the workers' compen

CAMBRIDGE, Mass., Nov. 6, 2019 /PRNewswire/ -- Blueprint Medicines Corporation (NASDAQ: BPMC), a precision therapy company focused on genomically defined cancers, rare diseases and cancer immunotherapy, today announced that an abstract for the ongoing Phase 2 PIONEER clinical trial evaluating avapritinib for the treatment of indolent and smoldering systemic mastocyt

BALTIMORE, Nov. 6, 2019 /PRNewswire/ -- Thermo Fisher Scientific announced the launch of its

SAN DIEGO, Nov. 6, 2019 /PRNewswire/ -- Medical Marijuana, Inc. ("the Company") (OTC: MJNA), the first-ever publicly traded cannabis company in